ConTIPI Medical: Funding, Investors & Team (Sep 2026)
ConTIPI Medical offers vaginal solutions that are disposable and non-surgical for women with various Pelvic Floor Disorders (PFD's). These solutions allow women to directly manage their condition and have already been successfully developed and brought to market. The Impressa Device, marketed by Kimberly Clark Inc. under the Poise® brand, is an example of this concept and is used for Stress Urinary Incontinence. ConTIPI Medical's second product, the ProVate Device, is intended for non-surgical management of Pelvic Organ Prolapse (POP) and has received a CE Mark for marketing in the EU. It is currently undergoing final clinical studies in the USA. Both devices are delivered in a wrapper and can be easily used at home. They are inserted vaginally using an applicator, which compresses them to a small size. Once inserted, the applicator deploys the device, providing support to specific areas along the vaginal walls. At the end of use, the device is removed with a pull of a string, reducing its size and then disposed of. These devices empower women to take control of their medical issues and use them in privacy and convenience. The ProVate device was specifically designed for women with Pelvic Organ Prolapse who prefer non-invasive management. Traditional pessaries have high discontinuation rates and many users are reluctant to use reusable devices that are difficult to insert and remove. The ProVate disposable device solves these issues by providing vaginal support that can be inserted and removed by the user at home.
ConTIPI Medical has raised $40.0M across 1 funding round on record, the most recent an undisclosed round of $40.0M announced in Jun 2023.
That round is above the $2.3M median round size for Community and Lifestyle companies tracked on FundedIQ over the last two years.
ConTIPI Medical Company Profile and Key Stats
Latest funding round on record: Jun 2023.
ConTIPI Medical Funding Rounds
ConTIPI Medical Founders and Leadership Team
No contact details are on record for this team yet.
ConTIPI Medical Funding Compared to Other Community and Lifestyle Startups
ConTIPI Medical's latest round of $40.0M is above the median round in Community and Lifestyle. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ConTIPI Medical in Community and Lifestyle and Caesarea
Companies Similar to ConTIPI Medical
InterCure is a manufacturer and distributor of pharmaceutical medical cannabis products.
Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering…
IM Cannabis is a company that manufactures and disseminates medical marijuana. They provide various products…
Else Nutrition offers plant-based nutrition products for the infant, toddler, children, and adult markets. It…
Jotit is an innovative educational technology company that utilizes handwriting tools to assist children,…
FEMSelect is revolutionizing women's health with their cutting-edge technology platform. They have developed…
The Daily Dev platform provides a community of developers with opportunities to expand their knowledge, work…
Crowdvocate helps B2B organizations draw in their clients consequently (trigger-based) all through their…
Mindspace is a boutique flex space provider, presenting a global mindset with a local flavor. We redefine the…
Noveto Systems produces focussed audio solutions, creating Virtual Headphones - Headphones without Headphones
Petfolk is a veterinary healthcare organization that offers an integrated platform for veterinarians, pets,…
Founded in 2017, WeRoad is one of Europe’s fastest-growing adventure travel platforms for Millennial and Gen…
ConTIPI Medical Funding FAQs
What does ConTIPI Medical do?
ConTIPI Medical offers vaginal solutions that are disposable and non-surgical for women with various Pelvic Floor Disorders (PFD's). These solutions allow women to directly manage their condition and have already been successfully developed and brought to market. The Impressa Device, marketed by Kimberly Clark Inc. under the Poise® brand, is an example of this concept and is used for Stress Urinary Incontinence. ConTIPI Medical's second product, the ProVate Device, is intended for non-surgical management of Pelvic Organ Prolapse (POP) and has received a CE Mark for marketing in the EU. It is currently undergoing final clinical studies in the USA. Both devices are delivered in a wrapper and can be easily used at home. They are inserted vaginally using an applicator, which compresses them to a small size. Once inserted, the applicator deploys the device, providing support to specific areas along the vaginal walls. At the end of use, the device is removed with a pull of a string, reducing its size and then disposed of. These devices empower women to take control of their medical issues and use them in privacy and convenience. The ProVate device was specifically designed for women with Pelvic Organ Prolapse who prefer non-invasive management. Traditional pessaries have high discontinuation rates and many users are reluctant to use reusable devices that are difficult to insert and remove. The ProVate disposable device solves these issues by providing vaginal support that can be inserted and removed by the user at home.
How much funding has ConTIPI Medical raised?
ConTIPI Medical has raised $40.0M across 1 round on record. The most recent is an undisclosed round of $40.0M announced in Jun 2023.
When did ConTIPI Medical last raise funding?
ConTIPI Medical's most recent funding round on record is an undisclosed round of $40.0M, announced in Jun 2023.
Who founded ConTIPI Medical?
FundedIQ lists Elan Ziv (Founder) at ConTIPI Medical.
Where is ConTIPI Medical headquartered?
ConTIPI Medical is based in Caesarea, Hefa, Israel.
How many employees does ConTIPI Medical have?
ConTIPI Medical is in the 1-10 employee band.
How does ConTIPI Medical's funding compare to other Community and Lifestyle startups?
ConTIPI Medical's latest round of $40.0M is above the $2.3M median round size for Community and Lifestyle companies on FundedIQ across 1,484 tracked companies over the last two years.
About FundedIQ's ConTIPI Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ConTIPI Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.